Striverdi Respimat

Active Ingredient(s): Olodaterol Respimat
FDA Approved: * July 31, 2014
Pharm Company: * BOEHRINGER INGELHEIM
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Striverdi Respimat Overview

Olodaterol (trade name Striverdi Respimat /strvrdi rspmæt/ STRIV-r-dee RES-pim-at) is an ultra-long-acting β adrenoreceptor agonist (ultra-LABA) used as an inhalation for treating patients with chronic obstructive pulmonary disease (COPD), manufactured by Boehringer Ingelheim.[2] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 4.3 Pharmadynamics 5 History 6 References 7 External links Med...

Read more Striverdi Respimat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Olodaterol

Recent Striverdi Respimat Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Olodaterol Respimat

Spray: Spray
Spray, Metered: 0.0025mg/inh, 2.5mg/inh

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Striverdi Respimat: (1 result)

Sorted by National Drug Code

0597-0192 Striverdi Respimat 2.5 ug/1 Respiratory (Inhalation) Spray, Metered by Boehringer Ingelheim Pharmaceuticals, Inc.

Other drugs which contain Olodaterol Respimat or a similar ingredient: (1 result)

OLODATEROL